1. Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials. (January 2019) Authors: Kanjanapan, Y.; Day, D.; Butler, M.O.; Wang, L.; Joshua, A.M.; Hogg, D.; Leighl, N.B.; Razak, A.R. Abdul; Hansen, A.R.; Boujos, S.; Chappell, M.; Chow, K.; Sherwin, B.; Stayner, L.-A.; Soultani, L.; Zambrana, A.; Siu, L.L.; Bedard, P.L.; Spreafico, A. Journal: European journal of cancer Issue: Volume 107(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗